The forecast for pancreas malignant neoplasms mortality in Canada indicates a steady rate of 13.0 deaths per hundred thousand persons standardized from 2024 to 2028. Over the last two years, the trend remains static with no variations observed. Compared to 2023, where the rate was 13.0 as well, the forecast suggests no significant changes expected in the near future.

Future trends to watch for:

Advancements in detection and treatment methods that may impact mortality rates.
Potential demographic shifts affecting incidence and mortality.
Healthcare policy changes that could influence disease management and outcomes.